Revascularization's Benefits in HFrEF Linked to Gains in LV Function - TCTMD

In a surprise, PCI seemed to have an edge over CABG. Data from the ongoing REVIVED-BCIS2 trial may provide clarity.

For patients who have heart failure with reduced ejection fraction (HFrEF) and coronary artery disease, improvements in LV function after revascularization are linked to better long-term outcomes, an… [+7571 chars]

full article...